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Abstract Problem formulation is the ﬁrst step in
environmental risk assessment (ERA) where policy
goals, scope, assessment endpoints, and methodology
are distilled to an explicitly stated problem and
approach for analysis. The consistency and utility of
ERAs for genetically modiﬁed (GM) plants can be
improved through rigorous problem formulation (PF),
producing an analysis plan that describes relevant
exposure scenarios and the potential consequences of
these scenarios. A properly executed PF assures the
relevance of ERA outcomes for decision-making.
Adopting a harmonized approach to problem
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Introduction
Risk assessment is widely used in decision-making
concerning the release of genetically modiﬁed (GM)
plants into the environment (EFSA 2006). The
process of integrating the likelihood and conse-
quences of exposure, in terms of harm, forms the
basis of environmental risk assessment (ERA). As the
ﬁrst step in ERA, the problem formulation (PF)
establishes the parameters that are of greatest
relevance to the assessment.
A variety of national, regional, and international
approaches to ERA of GM plants are emerging (Hill
2005), and these contain differing legislative triggers,
terminology, and guidance regarding how the assess-
ments are to be performed. The apparent differences
among various assessment protocols obscure their
similar underlying principles of case-by-case compar-
ative risk assessment. Clarifying these underlying
principlescanleadtoclearerassessmentsandimproved
communication among interested and affected parties.
Recognizing common principles for PF will encourage
harmonized approaches for risk assessment and may
helplessdevelopedcountriestoformulateeffectiveand
relevant biosafety regulations for GM plants.
This paper proposes a common PF framework for
environmental risk assessment of GM plants (Fig. 1).
The framework does the following: (i) it provides a
common language for the evaluation and communica-
tion of similarities and differences among various
assessment regimens (see box—Glossary of Terms);
(ii) it affords the necessary ﬂexibility for further
evolution and improvement of assessments and their
harmonization; (iii) it offers a template for environ-
mental assessment that may be applied in emerging
national or regional regulatory guidance; and (iv) it
aligns with the principles outlined in international
conventions such as the Cartagena Protocol on
Biosafety (http://www.cbd.int/biosafety/protocol.shtml)
and the phytosanitary standards of the International
Plant Protection Convention (IPPC 2001). The ERA
paradigm described by the US Environmental Pro-
tection Agency (EPA) (USEPA 1992, 1998) has been
used by the authors as a conceptual and procedural
basis for a common framework and terminology that
can be applied to ERAs for GM plants.
An inadequate PF may compromise the entire ERA
and add to the level of uncertainty in subsequent
decision-making. Frequent outcomes of this type of
failure are continuing requests for more data, dispro-
portionate risk mitigation measures and miscommuni-
cationofriskﬁndings;thisresultsinincreasedconcerns
about the environmental impact (Johnson et al. 2007;
Raybould 2006) and leads to delayed decision-making.
Some authors contend that such delays may lead to
increased negative environmental impacts because of
the consequent delays in the introduction of environ-
mentally beneﬁcial products (Raybould 2006, 2007).
Additionally, an ERA with a poorly developed PF may
have inadequately speciﬁed or inappropriate expres-
sions of the environmental value to be protected
(beneﬁtsincludingprocessesbywhichtheenvironment
producesresources),orinsufﬁcientclarityregardingthe
purpose and use of the data being collected. This report
presents a framework for constructing PFs that can be
applied to ERAs for GM plants.
Problem formulation framework
The ﬁrst step in ERA is problem formulation
(USEPA 1998), which has also been referred to as
hazard identiﬁcation (Hill 2005; OECD 2003). We
use the term problem formulation because it better
reﬂects the broad base of information regarding the
type and nature of potential adverse effects consid-
ered in an ERA for GM plants. A generic framework
for PF is described in this section and shown in
Fig. 1, recognizing that the case-by-case and com-
parative nature of ERAs for GM plants requires that
many aspects of the problem be shaped by case-
speciﬁc considerations as detailed in Developing the
Problem Formulation. At the core of the PF process
is the establishment of the ERA’s parameters (prob-
lem context) and the identiﬁcation of risks of greatest
relevance (problem deﬁnition).
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The problem context for risk assessment reﬂects
values derived from the broad environmental policies
and goals that direct risk analysis. Establishing the
problem context sets the parameters for the risk
assessment, including; protection goals, environmen-
tal scope, standard assessment endpoints (Suter 2000),
and assessment methodology (see Glossary of Terms
for deﬁnitions). In addition, the problem context
describes case-speciﬁc details of the GM crop and
certain baseline information used to determine the
relative risk that can be attributed to the modiﬁcation.
This baseline information can include details of the
biology of the parent organism and the nature of the
receiving environment (e.g., presence of sexually
compatible relatives, agronomic practices,presence of
nearby protected areas or species, climate, etc.).
Environmental risk assessments are initiated to
address protection goals, which may be deﬁned in law,
statutes, regulations, or guidance. Therefore, the
problem context may include problems and endpoints
for analysis with varying levels of relative importance
or relevance to the speciﬁc case that is ultimately
addressed in a particular ERA. In some cases, the
problem context is determined by the purpose and
scope of the ERA as described in regulatory standards.
Such standards may also prescribe the characteristics
of an appropriate comparator, general methodology to
be used, and criteria for distinguishing between
Fig. 1 Problem
formulation within the
paradigm for environmental
risk assessment (ERA). The
problem context develops
the parameters and
identiﬁes constraints for the
ERA, which may arise from
legal statutes and
institutional guidelines.
Problem deﬁnition shapes
the ERA into a manageable
form for analysis through
consideration of the case-
speciﬁc attributes of the
GM crop being assessed,
identiﬁcation of logically
relevant concerns, and
description of cause-effect
relationships
Transgenic Res (2010) 19:425–436 427
123meaningful and negligible differences (Australia
2000; Standards Australia 2004). For example, the
term ‘environment’ may require operational deﬁnition
as the scope of the ERA may need to address
anthropogenic as well as natural components of
environment in some jurisdictions (New Zealand
1996) but not in others (Australia 2000). Existing
guidance documents addressing current risk assess-
ment and risk management practices should be con-
sidered in the problem formulation process.
Importantly, the risk assessor must reﬁne a broadly
stated issue or concern into a relevant and manage-
able analysis. For instance, the stated protection goal
may be to provide an adequate level of protection of
biological diversity, http://www.cbd.int/biosafety/
protocol.shtml. A critical challenge of PF is to iden-
tify an observable, measurable property that ade-
quately reﬂects this desirable quality. To achieve this,
it is necessary to deﬁne assessment endpoints and
methodology that will direct the characterization of
risk and produce information that will be relevant for
decision-making. For example, beneﬁcial insects are
valued ecological entities and their abundance within
the agroecosystem is important and can serve as a
proxy or indicator of biological diversity. Therefore,
‘‘beneﬁcial insect abundance’’ constitutes a useful
assessment endpoint.
Problem deﬁnition
Problem deﬁnition is a distilling exercise that leads to
the identiﬁcation of reasonably postulated risks that
warrant further analysis, and removes from consid-
eration other potential but negligible risks. This is
done in the form of a scoping assessment that
generates and evaluates potential exposure scenarios
(Garcia-Alonso et al. 2006). Each exposure scenario
represents a meaningful problem that describes a
causally linked pathway, or set of circumstances, that
lead from the environmental release of the GM plant
through to an environmental entity of value that may
be adversely affected. Exposure when causally linked
Glossary of terms
Assessment endpoint—An explicit expression of the environmental value that is to be protected. Operationally, it is deﬁned by an
identiﬁed environmental entity of value that is susceptible to harm and an attribute that provides evidence of harm. For example,
beneﬁcial insects are valued ecological entities; abundance within the agroecosystem is an important attribute; ‘‘beneﬁcial insect
abundance’’ constitutes an assessment endpoint.
Environmental risk assessment (ERA)—The process of identifying signiﬁcant risks to the environment, estimating the level of risk,
and determining those risks that require measures to reduce the level of risk (USEPA 1998).
Environmental value—The beneﬁcial uses of the environment including the processes by which the environment produces resources.
Exposure—The contact or co-occurrence of a changed attribute of a GM plant with an environmental entity of value.
Exposure scenario—A particular set of circumstances describing the opportunity for harm to an environmental entity of value.
Harm—A negative outcome or effect of an action or event (=adverse effect).
Measurement endpoint—A measurable response to the changed attribute of the plant that is quantiﬁably related to the assessment
endpoint (USEPA 1998).
Phenotype—Observable characteristics of an organism described as physical or biochemical traits of an organism. For the purpose of
ERA, what constitutes a phenotype should reﬂect biologically relevant level of detail consistent with the particular risk comparison
being made.
Postulated risk—A potential harm that may manifest from a plausible exposure scenario and is subject to further analysis.
Problem context—The activity that establishes the parameters for the risk assessment, including policy goals, scope, assessment
endpoints, and methodology.
Problem deﬁnition—The activity that leads to the identiﬁcation of postulated signiﬁcant risks that warrant further analysis for a
speciﬁc ERA case and which leads to a speciﬁed analysis plan.
Problem formulation—The ﬁrst step in ERA whereby policy goals, scope, assessment endpoints, and methodology are developed into
an explicitly stated problem and an approach for analysis; comprised of the problem context and problem description.
Risk hypothesis—A tentative explanation taken to be true for the purpose of argument or investigation. This should not be confused
with scientiﬁc hypotheses, which are speciﬁc, testable postulates that will be part of the analytical phase of the ERA.
Scope—The state of the environment in which a situation exists.
Uncertainty—A form or source of doubt.
428 Transgenic Res (2010) 19:425–436
123to harm allows for the description of risk as an
adverse consequence from exposure.
In distilling the problem to a relevant form for
analysis, the problem deﬁnition considers the protec-
tion goal and the speciﬁc case; this encompasses the
plant being modiﬁed (the appropriate comparator),
the nature of the GM plant, and the environment in
which exposure is likely. Initially, this is a mental
exercise or an abbreviated assessment. Experience
with both GM and non-GM plants helps to identify
the potentially meaningful problems. No single PF is
likely to address every concern; rather, each concern
that is eventually deemed relevant to the GM plant
will be subject to a speciﬁc PF within the ERA.
The degree to which concerns are addressed within
a given assessment (such as a regulatory dossier) will
likely vary from case to case. Many concerns or
questions of risk may be readily answered on the
basis of prior knowledge and this prior knowledge
may rule out some scenarios as insubstantial. For
instance, for maize planted in the European Union,
potential harm resulting from pollen-mediated gene
ﬂow to a sexually compatible wild relative is not a
problem that requires analysis, due to the absence of
wild relatives. The degree to which the ERA formally
poses hypotheses and tests them with prior data varies
depending on how and by whom the risk assessment
will be used.
Many of the concerns included in the problem
deﬁnition for a GM plant are general to all ERAs, and
descriptions may be found in legislation, policy
papers, guidance documents, and descriptions of
existing risk analysis/management frameworks. In
addition to general concerns, features that are speciﬁc
to each particular case should be documented in each
PF. These include consideration of the speciﬁc GM
plant event, the environment where it is released, and
practices associated with its use. It is therefore
necessary to evaluate whether harm could arise from
a changed plant attribute by asking several questions:
What must happen for harm to occur? Is there a
reasonable causal pathway to harm? What is the
seriousness and likelihood of harm? Hypotheses of no
harm form the basis of a hypothesis-driven approach
to addressing these questions.
Thus, problem deﬁnition will achieve the follow-
ing: (1) select relevant assessment endpoints based on
policy objectives, (2) postulate reasonable exposure
scenarios that might result in environmental harm
arising from an activity or use of the GM plant or its
processed form, and (3) identify those scenarios that
merit detailed risk characterization. Addressing prob-
lem deﬁnition in the manner detailed in this paper
seeks to reduce the development of policies which do
not identify and address risks appropriately and may
become de facto barriers to the use of GM plants.
The deﬁnition of harm associated with GM plant
release should relate to commercial and regulatory
intent. For instance, the UK Farm Scale Evaluation
Trials (http://www.defra.gov.uk/environment/gm/fse/
) considered how GM cropping systems compared to
current cropping practice in the United Kingdom and
assessed whether the use of broad-spectrum herbi-
cides with GM plants would reduce the levels of
farmland biodiversity (including weeds). The
improved weed control from the pattern of use of the
herbicide in two of the three GM cropping systems
examined was described as ‘harmful’. Such a char-
acterization of harm is meaningful only to the extent
that it is consistent with the regulatory intent under
which the assessment is conducted.
Exposure
Exposure is the contact or co-occurrence of the
modiﬁed attribute of the GM crop with an environ-
mental entity of value. For instance, for a GM plant
expressing an insect resistance trait and co-occurring
in a given environment with a presumed sensitive
organism (the entity of value), there must be a
plausible pathway for exposure of the organism to the
modiﬁed plant attribute (an insect toxin in this
example). The description of this pathway represents
an exposure scenario. Thus, for Lepidoptera-active
Cry1 proteins expressed in maize pollen, the inges-
tion of pollen occurring on milkweed in and around
maize ﬁelds by a monarch butterﬂy is considered a
reasonable exposure scenario for ERA (Sears et al.
2001; Wolt et al. 2003).
Management of the GM plant—including activi-
ties such as growing, propagating, breeding, produc-
ing, processing, importing, transporting, disposing,
and using—will inﬂuence development of exposure
scenarios. Worst-case assumptions regarding expo-
sure and the consequences of exposure are frequently
used in early stages of ERA to focus on substantive
risks that warrant further consideration. When worst-
case considerations indicate the possibility of harm,
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determine if the concern remains under more realistic
conditions. Conversely, a ﬁnding of minimal harm in
a worst-case scenario would allow for a reasonably
and conservatively stated ﬁnding of no likely harm
under realistic conditions of environmental release.
For example, a worst-case risk assessment for
introgression of virus resistance from transgenic
Brassica napus into wild brassica populations shows
B. nigra and B. napus will hybridize when pollinated
manually (Raybould and Cooper 2005), which
requires reformulation of the problem to consider
whether hybridization will occur spontaneously. The
opportunity for spontaneous hybridization in this case
is very low, so there is no likely harm under ﬁeld
conditions. For any given case, there thus needs to be
a consideration of whether the potential harm arising
from exposure is sufﬁciently uncertain as to require
further analysis of exposure and its consequence.
Lack of a reasonable exposure pathway can result
in a determination of negligible risk, since without
exposure there is no opportunity for harm. A variety
of means may be used to postulate reasonable
scenarios. Standard problem deﬁnition methods
(Hayes et al. 2007) may be as simple as using
checklists or brainstorming, but they may also extend
to more rigorous and systematic methods (Hayes
et al. 2004). The nature and formality of the exercise
will be case dependent and will reﬂect preferences
and approaches of the responsible authority. Regard-
less of the approach used, transparency is important
to all of the interested and affected parties.
Reasonable risks
The standard for any ERA should be focusing on
reasonably postulated risk to support effective and
efﬁcient decision making. Of the many hypothetical
risks that can be described during problem deﬁnition,
most can be readily characterized as negligible. For a
few the probable magnitude or signiﬁcance of harm
may require more detailed consideration which
involves further elaboration of the exposure scenario
into a general statement of concern and a sequence of
events linking exposure to a consequence arising
from exposure, as shown in the Bacillus thuringiensis
(Bt) maize and monarch butterﬂy risk assessment
(Sears et al. 2001).
Developing the problem formulation
In developing the PF, the overarching protection
goals presented in law, regulation, or guidance must
be focused into case-speciﬁc objectives with clearly
deﬁned assessment endpoints and risk hypotheses.
These lead within the problem deﬁnition to develop-
ment of the conceptual model and translation into an
analysis plan focused on speciﬁc testable hypotheses
and relevant measurement endpoints.
Assessment endpoints
The starting point for the problem deﬁnition is
selection of assessment endpoints relevant to the
speciﬁc case under consideration, which is an
outgrowth of the problem context, as outlined above.
The assessment endpoint is an explicit expression of
environmental value and is operationally deﬁned as
an environmental entity of value susceptible to harm,
such as a certain species, and an attribute that
provides evidence of harm, such as population size
(USEPA 1998). Examples of assessment endpoints
typically used in ERA for GM plants are abundance
of beneﬁcial organisms in a crop ﬁeld and population
size of wild relatives of the GM plant; while neither is
direct evidence of harm per se, substantive changes in
these attributes would be cause for further detailed
assessment. The ecological entities of value and their
measurable attributes should also be recognized in a
conceptual model.
Risk hypotheses
Risk hypotheses arise from the consideration of
potentially signiﬁcant risks. The risk hypothesis is
used for clariﬁcation and articulation of the relation-
ships identiﬁed through problem deﬁnition (USEPA
1998). A risk hypothesis stands as an assumption
regarding the cause-effect relationships among chan-
ged attributes, sources, exposure routes, endpoints,
responses, and measures relevant to the ERA. In the
analysis phase of the ERA, the risk hypothesis is
translated into one or more experimental hypotheses
that can be used for testing and corroboration. The
use of risk hypotheses can increase clarity in deﬁning
and testing postulated risks as well as transparency in
communicating the intended purpose of a given ERA.
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One of the pitfalls of ERA that can be prevented by
PF is treatment of the plant as a theoretical entity.
The PF deﬁnes the plant being modiﬁed in tangible
terms based on the plant’s biology.
Deﬁning and identifying differences
that may plausibly lead to harm
Among the factors that should be considered in
problem deﬁnition, the nature, magnitude, and
signiﬁcance of the changes in the GM plant are of
primary importance since they will direct the course
of actions required for risk characterization. For
instance, modiﬁcation involving introduction of a
single trait like a Cry1 protein allows for a focused
consideration of cause (exposure to Cry1 through
pollen release in a given environment) and effect
(harm or toxic effects occurring to an entity of value,
such as a butterﬂy). In the case of multiple or
stacked traits, PF considers each trait, e.g. Cry1 and
Cry3, independently as well as the potential for the
traits to interact. Instances in which unintended
changes are detected by comparison to a baseline
and sufﬁciently differ from the baseline may require
further analysis. Or an early-stage decision may be
made to discontinue development of the GM plant if
the unintended change represents an undesirable
phenotype.
To date, the vast majority of phenotypes that have
been assessed have been traits for herbicide tolerance
and insect resistance. As other phenotypes are
developed, the PF may need to consider more
complex changes and the possibility of unintended
or unexpected consequences to the modiﬁcation.
Transcription factors and mechanisms that affect
metabolic proﬁles, e.g., RNAi, are examples of newer
traits that involve less deﬁned modes of action. In
these cases, a sound model for the PF is essential to
link an intended change to a postulated harm through
plausible pathways of exposure and its adverse
effects. Phenotypic alterations that may arise from
these molecular level changes, and which may
plausibly lead to harm, will need to be identiﬁed in
the PF process (Nickson 2008).
Comparative risk assessment is a fundamental
principle of GM plant ERA. As described in the
problem context phase, the endpoint measurement for
GM plants is made relative to comparator plants and
cropping practices. Biologically meaningful differ-
ences observed between the GM plant and its
comparators are attributed to the outcome of the
genetic modiﬁcation. The risk will be evaluated
comparatively; i.e., on the basis of a hypothesis of no
biologically meaningful differences that could pro-
duce an adverse effect on the assessment endpoint
associated with the GM phenotype versus the non-
transformed comparator, or on the basis of no
environmentally relevant difference in the system
where the GM phenotype is released. Therefore, it is
necessary to establish the basis for comparability and
parameters to identify meaningful changes in the
transformed plant. The PF seeks relevant existing
information describing the environmentally meaning-
ful case-speciﬁc attributes of the GM plant under
conditions of its release, which will determine the
nature and scope of the ERA. The types of informa-
tion that should be considered at this stage are
existing peer reviewed literature, information gener-
ated during product development, and previous
regulatory decisions and assessments. In the case of
GM plants without an unmodiﬁed counterpart, a
direct comparator does not exist but indirect com-
parators will exist in the process or ecosystem where
the new plant will occur.
All available knowledge should be applied in
order to identify meaningful differences for analysis.
Knowledge of the trait, the host, and the host-trait
combination may be found in existing information.
Further information may also be available that
describes the gene stability, trait selectivity, level
of expression, and mode of action of the change that
is manifested. This precursor information will typi-
cally establish the comparability of the transformed
event relative to a near isoline as well as to the
normal range of a component seen in the crop.
Information of this type is commonly required in the
overall preparation of regulatory dossiers for GM
plants and is frequently available in advance of the
ERA; it thus allows for the ERA to be shaped in a
way that is relevant to the case being studied. This
information alone does not establish harm or lack
thereof, but it does establish the properties of the
intended change. Importantly, the precursor informa-
tion should help deﬁne those environmental entities
most likely to be sensitive to the change manifested
in the GM plant.
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The type of environmental release determines the
intended use, scale, and likely location of GM plants
within a receiving environment. Three types of
releases applicable to GM plants are conﬁned ﬁeld
trials, incidental release in the course of transit
(typically an outcome of moving commodities to
processing facilities), and unconﬁned commercial
release. The speciﬁc environmental concerns consid-
ered and the data needed may differ for a small-scale
ﬁeld trial that is subject to conﬁnement measures
versus a wide-scale unconﬁned release because
mitigating factors are used (e.g., buffer zones and
ﬁeld offset distances in the case of conﬁned ﬁeld
trials). The ways in which environmental concerns
are addressed for a cultivated crop may be different
than for an imported grain (incidental release).
Location in space and time, especially as it relates
to environmental entities of value, will have a strong
bearing on the development of exposure scenarios. In
some cases, it may be useful to distinguish different
land use types (e.g., urban, natural vegetation, agri-
culture, and aquatic) that will be relevant to the ERA.
Although the GM plant may occur in several land use
types, the focus of concern is typically the agroeco-
system and its immediate surroundings and environ-
ments subject to special protections (such as habitats
for threatened or endangered species). Therefore,
when identifying speciﬁc attributes of assessment
endpoints, it is important to draw clear distinctions
among the environmental impacts in farmed, unf-
armed, or semi-natural environments. This has not
been done in much of the discussion of ‘escapes’ and
‘invasions’ to date. For instance, almost all examples
of invasive hybrids (Ellstrand et al. 1999) are arable
weeds and consequently pose a potential problem for
agronomy, but they will not necessarily be of direct
concern for native species or plant community
conservation. For example, B. napus can establish
more readily in disturbed habitats and is therefore
more likely to have an adverse effect in agricultural
environments than in native plant communities.
Deﬁning exposure in the PF
Potential biotic and abiotic interactions may be
important to the PF. Most relevant in this regard is
the description of the environmental fate of unique
products expressed in the GM plant. Together with
environmental fate, expression will determine the
potential for environmental persistence and accumu-
lation, and thus exposure. For example, a decline in
Cry1A expression levels in GM maize as the plant
reaches maturity would mean that the consequences
of exposure will most likely be restricted to the in-
crop phase of the production cycle. In other cases, the
exposure may be restricted to ﬁelds where the crop is
grown. For example, a transgene introduced to a
native plant by outcrossing must be stably introgres-
sed into the genome of the receptor population and
persist in order for pollen ﬂow to be a signiﬁcant
route of exposure; if the PF establishes that intro-
gression is not possible, the ERA should focus on the
ﬁelds where the crop is grown.
Conceptual model
The conceptual model describes a plausible scenario
of how harm may arise from use of the GM crop in a
way that allows for a characterization of risk. The
purpose of the conceptual model is to readily
communicate how the ERA will be conducted.
Conceptual models take many forms such as simple
statements, an outline of activities, ﬂow charts, or
diagrams. Conceptual models describe key relation-
ships between the GM plant release and possible
environmental consequences of that release. The
conceptual model describes the pathway for analysis
by setting the problem in perspective and establishing
the proposed relationships between exposure and
effect.
Vagueness in development of the conceptual
model leads to uncertainty in the application of
subsequent risk ﬁndings. Vagueness may arise from
uncertain regulatory policy, where the protection goal
is not clearly articulated. The conceptual model
should explicitly recognize the assessment endpoints
that have been established, i.e., the entities of value
and their measurable attributes. The conceptual
model can control both variability and uncertainty
in the risk assessment by deﬁning boundaries for the
assessment such as the region of use, scale of release,
or appropriate comparators.
Diagrammatic conceptual models are particularly
powerful as shown in Fig. 2 (Sears et al. 2001). In
this example, the various elements contributing to
exposure and effect are outlined in a way that
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means of evaluating the risks of Bt maize on monarch
butterﬂy larvae populations.
Analysis plan
Once reasonable scenarios for analysis have been
identiﬁed and described through conceptual models,
they are shaped into an analysis plan. The analysis
plan describes the various measures to be used in the
assessment, the subsequent characterizations, studies
to be conducted, and the appropriate tier for analysis.
Importantly, the analysis plan prescribes the manner
in which the results should be expressed for risk
characterization.
Tiered analysis
The analytical plan should identify the level of testing
and analysis. Well-developed testing schemes for
conventional pesticides utilize a tiered approach
(Hassan 1998a, b), and this approach should also be
considered as a cornerstone for effective GM crop
ERA. Tiered testing ﬁrst addresses broad questions
using simple experimental designs with unambiguous
outcomes that conservatively cast projections; i.e.,
appropriately conceptualized early tier assessments
should have a low rate of false-negative risk determi-
nation but may well have a high rate of false-positives,
which will necessitate higher tier assessments.
Problem formulation should seek hypotheses that
can be tested in a tiered fashion, because
corroboration of hypotheses of no harm when tested
with conservative assumptions provides high conﬁ-
dence of low risk. Subsequent tests may reﬁne earlier
studies or may progress to studies that are more
realistic and complex. These subsequent tests are
triggered when the risk assessment requires that more
exacting probabilities of exposure and their conse-
quence are needed for decision-making. Since a given
tier of testing is only prompted by the risk assess-
ment, the iterative approach effectively focuses
consideration to the most relevant concerns and
conserves time and resources.
The usefulness of tiered testing and assessment
for GM plants is being increasingly recognized
(Dutton et al. 2003; Garcia-Alonso et al. 2006;
Romeis et al. 2008). Published schemes vary in their
speciﬁcs such as the number of tiers and the nature of
tests, but all recognize the critical nature of tiered
approaches to iteratively address risk in a manner
consistent with the level of concern and the uncer-
tainty in the assessment.
Measurement endpoints
The analysis plan must establish a relevant conse-
quence of exposure consistent with the protection
goals articulated in the problem context. This repre-
sents measurable effects to an environmental entity of
value or its surrogate in response to a changed
attribute of the GM plant to which the entity is
exposed, where the attribute represents the transgenic
protein or some other change of importance. The
expression of the measurement endpoint must be
consistent with the described route, frequency, dura-
tion, and intensity of exposure for the attribute
relative to the entity of value.
Most assessment endpoints are not measured
directly; instead, other characteristics called measure-
ment endpoints are determined (USEPA 1998). For
GM plant ERAs, a measurement endpoint is a
measurable response to the changed attribute of the
plant that is related to the assessment endpoint. For
instance, this may be an acute lethal concentration
resulting in the death of 50% of the test organisms
(LC50), or a chronic No Observable Adverse Effect
Level (NOAEL) measured for the entity of value or its
surrogate,oralteredfecundityinareceptorpopulation.
Often the analysis plan will also be concerned with
measures of system or receptor characteristics. These
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Fig. 2 Example of a conceptual model for ERA (Sears et al.
2001)
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123are characteristics of the ecosystem that inﬂuence the
behavior and location of entities of value relative to
the distribution of the GM plant. For example, life
history characteristics may affect the degree of
exposure or response to the GM plant. Therefore,
the analysis plan may involve determining the
abundance and distribution of the entity of value at
a relevant life stage within a landscape or region, as
in the assessment of Bt maize risk to the monarch
butterﬂy population (Sears et al. 2001).
Risk formulation
The analysis plan will establish the appropriate risk
formulation to be considered in the risk character-
ization. The risk formulation represents the way the
exposure measurement is related to the effect mea-
surement. In cases in which the assessment is
quantitative, the simplest form of risk formulation
may be a ratio or risk quotient (RQ) of exposure to
effect measurements, for instance, RQ = Expected
Environmental Concentration/LC50, (Wolt et al.
2003). In some instances, it will be possible to
develop a more fully probabilistic formulation of risk
(Sears et al. 2001). Not all risk formulations result in
quantiﬁable risk estimates; qualitative descriptors
(e.g., negligible, low, high) of risk may be used.
With respect to GM plants, the risk formulation is
frequently a qualitative, weight of evidence consider-
ation based on observations relative to a comparator;
that is, a determination as to whether the environ-
mental risk associated with the GM plant is no greater
than the risk associated with the conventional plant.
Quantitative descriptions can be used when assessing
risk for speciﬁc introduced proteins. For instance,
when considering a protein toxin expressed in a GM
plant, a threshold for concern arising from a ﬁrst-tier
study would be biologically signiﬁcant increased
mortality for a non-target organism exposed to the
puriﬁed protein as compared to a no-toxin control. If
this was shown for the ﬁrst-tier study, reﬁnement of
effects thresholds or higher tier studies under more
realistic exposure conditions (for example, using GM
plant material rather than the puriﬁed protein) would
be necessary in order to adequately address uncer-
tainties regarding the environmental relevance of
effects on non-target organisms.
Ideally, an established regulatory threshold for
concern (decision criterion) deﬁnes both the
appropriate risk formulation as well as the result that
would trigger regulatory concern. A pro forma
decision criterion is seldom found in the case of
GM plants. Decision criteria are determinations
within the ERA regarding further analysis of the risk
hypotheses. The decision criteria will relate to the
measurement of the harm (an adverse consequence of
exposure or an accepted surrogate measure) and the
risk (the manifestation of harm resulting from the
exposure that occurs). An example of a decision
criterion used in a ﬁrst-tier, non-target ERA is a
meaningful effect to the test organism at 109 the
reasonably anticipated exposure (Rose 2006). In
determining a decision criterion, the analytical plan
must consider the sufﬁciency of surrogates as
predictors of harmful effects.
Uncertainty
Uncertainty is inherent to risk analysis and can take
multiple forms including incomplete knowledge,
variability, or use of language that is vague, ambig-
uous or under-speciﬁed (Morgan and Henrion 1990).
Uncertainty that is ignored in the PF stage has the
potential to be propagated throughout the risk
assessment process. For instance, poorly deﬁned
harm or inappropriate assessment endpoints may
misdirect research or regulatory effort, and may even
lead to the imposition of unnecessary controls to
reduce risk. Regardless of its form, uncertainty must
be explicitly addressed in the ERA and the PF should
describe the approach to dealing with uncertainty.
The previously described concept of a tiered system
for both testing and assessment is critical for dealing
with uncertainties within the ERA in a conservative
manner. For instance, a ﬁnding of no harm under
worse-case assumptions should provide reasonable
certainty that there will be low risk to the environ-
mental entity of value under more realistic conditions
of exposure.
The PF should prescribe validated test systems as
much as possible and utilize conservative dosing
strategies consistent with the exposure scenario being
evaluated. There are opportunities to address uncer-
tainty through the use of conservatively cast assump-
tions within each tier of studies and assessment. Also,
since GM plants are assessed through a lines-of-
evidence approach, it is important that the ﬁndings of
any one element of the analysis correspond to other
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123evidence. The use of comparative assessment is a
further aspect of the ERA that acts to reduce
uncertainty.
The outcome of any ERA is subject to reinvesti-
gation based on new information arising from many
sources. For a particular PF, consideration should be
given to the state of uncertainty during development
of the analytical plan. For instance, initial testing
might identify potential risks that are considered
signiﬁcant but are, in fact, negligible (false positives)
or disregard potential risks that are considered
negligible but are, in fact, signiﬁcant (false nega-
tives). Subsequent research may identify risks that are
indeed signiﬁcant and unexpected (surprises). Prob-
lem deﬁnition attempts to eliminate false negatives
and surprises by conservatively assuming in the ﬁrst
instance worst-case exposure scenarios. Conse-
quently, ERAs are likely to include characterization
of a number of false-positive risks. The issue relative
to false positives is the need for excessive resources
to assess negligible risks; this can be addressed
through the use of a staged protocol that iterates
through tiers. The iterative nature of the ERA allows
for the problem to be reformulated for further
analysis so as to better address residual uncertainty
from earlier stages of analysis.
Summary and recommendations
Environmental risk assessment is an analytical
approach with common elements practiced in various
regulatory regimes. Problem formulation deﬁnes the
goals, objectives, and scope of the ERA in a way that
condenses a multitude of concerns within a broadly
stated statutory need into a focused problem relevant
to the speciﬁc GM plant and release being consid-
ered. As such, PF is the juncture at which the problem
context for risk management is transformed through
problem deﬁnition into an analytical plan including
relevant exposure scenarios and potential conse-
quences (harm) arising from those scenarios. Formal
deﬁnition of the ERA through a properly executed PF
assures the relevance of the risk assessment outcomes
for the purpose of decision-making.
In this paper, we have described a framework for
PF and have identiﬁed opportunities for strengthening
the ERA of GM plants. Adoption of a consistent
process for undertaking ERAs, using PF as a focusing
step, along with the use of common terminology
provides an opportunity to achieve an appropriate
degree of uniformity and harmonization in
approaches to ERA globally. Critical to the success
of ERA is the deﬁnition in the PF of clearly
articulated pathways for analysis and a distinct
process for tiered analysis that matches the level of
data generation and synthesis to the nature of
concern, degree of uncertainty, and environmental
scope of the case being considered. Implicit in this
process is reliance on familiarity, experience, and
existing knowledge in guiding the extent of analysis
required to address questions of risk.
Harmonization of the PF and ERA process will
strengthen the ability of ERAs to answer the appro-
priate questions necessary for risk management
decision making and increase the acceptance of the
ERA process globally. While adopting a consistent
ERA process may not ensure global acceptance of a
particular ERA, it will enhance understanding and
increase the ease of evaluation of ERAs conducted
within different contexts. Adoption of PF is a critical
ﬁrst step for providing transparency in developing
and communicating problems that are relevant to
analysis with an ERA framework.
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